J. Mcmurray

发表

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.

J. McMurray, I. Abdullah, H. Dargie, 1991, British heart journal.

Effects of central sympathetic inhibition on heart rate variability during steady‐state exercise in healthy humans

S. Galloway, M. Nimmo, G. de Vito, 2002, Clinical physiology and functional imaging.

ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.

D. Murdoch, T. McDonagh, H. Dargie, 2001, American heart journal.

A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise.

J. McMurray, T. Aitchison, H. Dargie, 1999, Chest.

Coronary heart disease.

H. Dargie, J. Mcmurray, 1991, BMJ.

Adrenomedullin selectively inhibits angiotensin II‐induced aldosterone secretion in humans

J. McMurray, M. Petrie, J. Mcmurray, 2000, Journal of hypertension.

Plasma Endothelin in Chronic Heart Failure

J. McMurray, I. Abdullah, H. Dargie, 1992, Circulation.

Impact of nicorandil in angina: subgroup analyses

A. Skene, J. Hampton, M. Morris, 2004, Heart.

Heart failure – implications of the true size of the problem

J. McMurray, T. McDonagh, H. Dargie, 1996, Journal of internal medicine.

Placebo‐controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure

J. McMurray, D. Newby, H. Dargie, 1999, European journal of heart failure.

Left-ventricular dysfunction

J. Mcmurray, H. Dargie, C. Morrison, 1998, The Lancet.

Vasoconstrictor Effect of the Angiotensin-Converting Enzyme–Resistant, Chymase-Specific Substrate [Pro11D-Ala12] Angiotensin I in Human Dorsal Hand Veins: In Vivo Demonstration of Non-ACE Production of Angiotensin II in Humans

J. Connell, J. McMurray, M. Petrie, 2001, Circulation.

Effects of sympathetic inhibition on exertional dyspnoea, ventilatory and metabolic responses to exercise in normotensive humans.

S. Galloway, M. Nimmo, G. de Vito, 2000, Clinical science.

Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction.

J. Cleland, J. Cleland, M. Maclean, 1998, Cardiovascular research.

Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study.

A. Skene, J. Hampton, M. Morris, 2005, American Heart Journal.

The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro.

H. Dargie, J. Mcmurray, M. Clapperton, 1994, British journal of clinical pharmacology.

Structural and functional assessment of small arteries in patients with chronic heart failure.

J. Cleland, H. Dargie, J. Mcmurray, 1999, Clinical science.

Effects of ACE inhibitors on oxidation of human low density lipoprotein.

J. Reid, C. Hamilton, H. Dargie, 1994, British journal of clinical pharmacology.

Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure.

M. Petrie, M. Maclean, M. Love, 2001, Clinical science.

Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans.

M. Petrie, J. Mcmurray, J. Morton, 2001, British journal of clinical pharmacology.

Pulmonary and systemic responses to exogenous endothelin-1 in patients with left ventricular dysfunction.

J. Cleland, M. Maclean, H. Dargie, 1998, Journal of cardiovascular pharmacology.

Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

A. D. Cunningham, C. Morrison, I. Ford, 2001, Heart.

Synergism of histidyl dipeptides as antioxidants.

H. Dargie, J. Mcmurray, D. Miller, 1991, Journal of molecular and cellular cardiology.

Does luminol chemiluminescence detect free radical scavengers?

H. Dargie, J. Mcmurray, M. Clapperton, 1995, British journal of clinical pharmacology.

Fortnightly Review: Diagnosis and management of heart failure

J. McMurray, H. Dargie, J. Mcmurray, 1994, BMJ.

Trends in hospitalization for heart failure in Scotland 1980-1990.

J. McMurray, C. Morrison, T. McDonagh, 1993, European heart journal.

Biochemical detection of left-ventricular systolic dysfunction

H. Tunstall-Pedoe, D. Murdoch, I. Ford, 1998, The Lancet.

Evidence that a novel orally active NEP/ECE inhibitor blocks the vasoconstrictor response to big endothelin in human resistance arteries

C. Berry, M. Petrie, J. Mcmurray, 2002 .

The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people.

D. Arveiler, G. Luc, J. Ruidavets, 1999, Hypertension.

The reproducibility of symptoms during a submaximal exercise test in chronic heart failure.

T. McDonagh, T. Aitchison, H. Dargie, 1998, British journal of clinical pharmacology.

Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure

D. Murdoch, H. Dargie, D. Shapiro, 1999, Heart.

Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction.

J. Cleland, M. Maclean, H. Dargie, 1999, Journal of the American College of Cardiology.

Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.

J. Connell, M. Petrie, J. Mcmurray, 2001, Journal of the American College of Cardiology.

LEFT-VENTRICULAR DYSFUNCTION. AUTHORS' REPLY

H. Hense, H. Schunkert, U. Keil, 1998 .

Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population.

M. Woodward, H. Tunstall-Pedoe, G. Lowe, 1997, European heart journal.

Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer.

I. Ford, H. Dargie, J. Mcmurray, 1990, British heart journal.

Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils.

I. Abdullah, H. Dargie, J. Mcmurray, 1995, British Journal of Clinical Pharmacology.